Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling

Fig. 6

Differences in sensitivity of stem cell subtypes to chemotherapy. The box plots of the estimated IC50 for a cisplatin, b sunitinib, c methotrexate, d doxorubicin, e gemcitabine, and f vinblastine are shown for C1–C4 in TCGA cohort. P value in the box plots is for all groups. TCGA, The Cancer Genome Atlas; SCE_H, high stem cell enrichment; SCE_M, medium stem cell enrichment; SCE_L, low stem cell enrichment

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512